Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study

Christopher M Petrilli, Simon A Jones, Jie Yang, Harish Rajagopalan, Luke O'Donnell, Yelena Chernyak, Katie A Tobin, Robert J Cerfolio, Fritz Francois, Leora I Horwitz, Christopher M Petrilli, Simon A Jones, Jie Yang, Harish Rajagopalan, Luke O'Donnell, Yelena Chernyak, Katie A Tobin, Robert J Cerfolio, Fritz Francois, Leora I Horwitz

Abstract

Objective: To describe outcomes of people admitted to hospital with coronavirus disease 2019 (covid-19) in the United States, and the clinical and laboratory characteristics associated with severity of illness.

Design: Prospective cohort study.

Setting: Single academic medical center in New York City and Long Island.

Participants: 5279 patients with laboratory confirmed severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection between 1 March 2020 and 8 April 2020. The final date of follow up was 5 May 2020.

Main outcome measures: Outcomes were admission to hospital, critical illness (intensive care, mechanical ventilation, discharge to hospice care, or death), and discharge to hospice care or death. Predictors included patient characteristics, medical history, vital signs, and laboratory results. Multivariable logistic regression was conducted to identify risk factors for adverse outcomes, and competing risk survival analysis for mortality.

Results: Of 11 544 people tested for SARS-Cov-2, 5566 (48.2%) were positive. After exclusions, 5279 were included. 2741 of these 5279 (51.9%) were admitted to hospital, of whom 1904 (69.5%) were discharged alive without hospice care and 665 (24.3%) were discharged to hospice care or died. Of 647 (23.6%) patients requiring mechanical ventilation, 391 (60.4%) died and 170 (26.2%) were extubated or discharged. The strongest risk for hospital admission was associated with age, with an odds ratio of >2 for all age groups older than 44 years and 37.9 (95% confidence interval 26.1 to 56.0) for ages 75 years and older. Other risks were heart failure (4.4, 2.6 to 8.0), male sex (2.8, 2.4 to 3.2), chronic kidney disease (2.6, 1.9 to 3.6), and any increase in body mass index (BMI) (eg, for BMI >40: 2.5, 1.8 to 3.4). The strongest risks for critical illness besides age were associated with heart failure (1.9, 1.4 to 2.5), BMI >40 (1.5, 1.0 to 2.2), and male sex (1.5, 1.3 to 1.8). Admission oxygen saturation of <88% (3.7, 2.8 to 4.8), troponin level >1 (4.8, 2.1 to 10.9), C reactive protein level >200 (5.1, 2.8 to 9.2), and D-dimer level >2500 (3.9, 2.6 to 6.0) were, however, more strongly associated with critical illness than age or comorbidities. Risk of critical illness decreased significantly over the study period. Similar associations were found for mortality alone.

Conclusions: Age and comorbidities were found to be strong predictors of hospital admission and to a lesser extent of critical illness and mortality in people with covid-19; however, impairment of oxygen on admission and markers of inflammation were most strongly associated with critical illness and mortality. Outcomes seem to be improving over time, potentially suggesting improvements in care.

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: support from the Kenneth C Griffin Charitable Fund for submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Fig 1
Fig 1
Flow diagram of included participants. Covid-19=coronavirus disease 2019
Fig 2
Fig 2
Cumulative incidence function for discharge alive or death, by age group. Shading represents 95% confidence intervals
Fig 3
Fig 3
Cumulative incidence function for discharge alive or death, by heart failure, cancer, diabetes, and sex. Shading represents 95% confidence intervals
Fig 4
Fig 4
Cumulative incidence function for discharge alive or death, by admission oxygenation and D-dimer levels. Shading represents 95% confidence intervals
Fig 5
Fig 5
Cumulative incidence function for discharge alive or death, by C reactive protein and lymphocyte count. Shading represents 95% confidence intervals

References

    1. Guan WJ, Ni ZY, Hu Y, et al. China Medical Treatment Expert Group for Covid-19 Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708-20. 10.1056/NEJMoa2002032.
    1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (covid-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020. 10.1001/jama.2020.2648.
    1. Livingston E, Bucher K. Coronavirus disease 2019 (covid-19) in Italy. JAMA 2020. 10.1001/jama.2020.4344.
    1. Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to covid-19 in Italy. JAMA 2020. 10.1001/jama.2020.4683.
    1. CDC COVID-19 Response Team Severe outcomes among patients with coronavirus disease 2019 (covid-19) - United States, February 12-March 16, 2020. MMWR Morb Mortal Wkly Rep 2020;69:343-6. 10.15585/mmwr.mm6912e2.
    1. CDC COVID-19 Response Team Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 - United States, February 12-March 28, 2020. MMWR Morb Mortal Wkly Rep 2020;69:382-6. 10.15585/mmwr.mm6913e2.
    1. Richardson S, Hirsch JS, Narasimhan M, et al. and the Northwell COVID-19 Research Consortium Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with covid-19 in the New York City area. JAMA 2020. 10.1001/jama.2020.6775.
    1. Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020. 10.1001/jamainternmed.2020.0994.
    1. Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis 2020:ciaa272. 10.1093/cid/ciaa272.
    1. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with covid-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62. 10.1016/S0140-6736(20)30566-3.
    1. Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (covid-19). JAMA Cardiol 2020. 10.1001/jamacardio.2020.1017.
    1. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020. 10.1001/jama.2020.1585.
    1. Korean Society of Infectious Diseases and Korea Centers for Disease Control and Prevention Analysis on 54 mortality cases of coronavirus disease 2019 in the Republic of Korea from January 19 to March 10, 2020. J Korean Med Sci 2020;35:e132. 10.3346/jkms.2020.35.e132.
    1. Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in critically ill patients in the Seattle Region - case series. N Engl J Med 2020. 10.1056/NEJMoa2004500.
    1. Grasselli G, Zangrillo A, Zanella A, et al. COVID-19 Lombardy ICU Network Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA 2020. 10.1001/jama.2020.5394.
    1. NYC Health. Cases, hospitalizations and deaths. 2020. .
    1. Popescu I, Fingar KR, Cutler E, Guo J, Jiang HJ. Comparison of 3 Safety-Net Hospital Definitions and Association With Hospital Characteristics. JAMA Netw Open 2019;2:e198577.
    1. Fox J, Monette G. Generalized collinearity diagnostics. J Am Stat Assoc 1992;87:178-83 10.1080/01621459.1992.10475190.
    1. Imdad MU, Aslam M. mctest: multicollinearity diagnostic measures version 1.2.5 2018. .
    1. Venables WN, Ripley BD. Modern Applied Statistics. 4th ed Springer, 2002. 10.1007/978-0-387-21706-2.
    1. Venzon DJ, Moolgavkar SH. A method for computing profile-likelihood based confidence intervals. Appl Stat 1988;37:87-94 10.2307/2347496.
    1. Fine JP, Grey RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496-509 10.1080/01621459.1999.10474144.
    1. Grey RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 2019;16:1141-54 10.1214/aos/1176350951.
    1. Sfumato P. Goodness-of-fit for time-to-event data. 2020. .
    1. Melby C, Gu J, Rojanasakul M. Mapping New York City hospital beds as coronavirus cases surge. 2020 .
    1. World Health Organization. Hospital beds (per 10 000 population). 2020 .
    1. Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005;353:1685-93. 10.1056/NEJMoa050333.
    1. Bellani G, Laffey JG, Pham T, et al. LUNG SAFE Investigators. ESICM Trials Group Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016;315:788-800. 10.1001/jama.2016.0291.
    1. Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock [published Online First: 2018/06/26]. Lancet 2018;392:75-87. 10.1016/S0140-6736(18)30696-2.
    1. Halpin DMG, Faner R, Sibila O, Badia JR, Agusti A. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? Lancet Respir Med 2020;8:436-8. 10.1016/S2213-2600(20)30167-3.
    1. Simonsen L, Fukuda K, Schonberger LB, Cox NJ. The impact of influenza epidemics on hospitalizations. J Infect Dis 2000;181:831-7. 10.1086/315320.
    1. Zhou H, Thompson WW, Viboud CG, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis 2012;54:1427-36. 10.1093/cid/cis211.
    1. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138-50. 10.1056/NEJMra021333.
    1. Danzi GB, Loffi M, Galeazzi G, Gherbesi E. Acute pulmonary embolism and COVID-19 pneumonia: a random association? Eur Heart J 2020:ehaa254. 10.1093/eurheartj/ehaa254.
    1. Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res 2020;S1931-5244(20)30070-0. 10.1016/j.trsl.2020.04.007.
    1. Schmidt FM, Weschenfelder J, Sander C, et al. Inflammatory cytokines in general and central obesity and modulating effects of physical activity. PLoS One 2015;10:e0121971. 10.1371/journal.pone.0121971.
    1. Caër C, Rouault C, Le Roy T, et al. Immune cell-derived cytokines contribute to obesity-related inflammation, fibrogenesis and metabolic deregulation in human adipose tissue. Sci Rep 2017;7:3000. 10.1038/s41598-017-02660-w.
    1. Geovanini GR, Libby P. Atherosclerosis and inflammation: overview and updates. Clin Sci (Lond) 2018;132:1243-52. 10.1042/CS20180306.
    1. Jacobs D, Blackburn H, Higgins M, et al. Report of the conference on low blood cholesterol: mortality associations. Circulation 1992;86:1046-60. 10.1161/01.CIR.86.3.1046.

Source: PubMed

3
Tilaa